Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabinoid CB1 Receptor Agonist Treatment in Severe Chronic Anorexia Nervosa

NCT00760695 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT00760695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00760695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabinoid CB1 Receptor Agonist Treatment in Severe Chronic Anorexia Nervosa
Lead sponsor
Odense University Hospital
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2008
Completion date
December 31, 2011
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anorexia nervosa